491 related articles for article (PubMed ID: 15536109)
21. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
[TBL] [Abstract][Full Text] [Related]
22. Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies.
Cleophas TJ; van Ouwerkerk BM; van der Meulen J; Zwinderman AH
Angiology; 2001 Jul; 52(7):469-75. PubMed ID: 11515986
[TBL] [Abstract][Full Text] [Related]
23. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.
Weber K; Bohmeke T; van der Does R; Taylor SH
Cardiovasc Drugs Ther; 1996 May; 10(2):113-7. PubMed ID: 8842502
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure.
Franz IW; Agrawal B; Wiewel D; Ketelhut R
Clin Investig; 1992; 70 Suppl 1():S53-7. PubMed ID: 1350485
[TBL] [Abstract][Full Text] [Related]
27. Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.
Wai B; Kearney LG; Hare DL; Ord M; Burrell LM; Srivastava PM
Cardiovasc Diabetol; 2012 Feb; 11():14. PubMed ID: 22330091
[TBL] [Abstract][Full Text] [Related]
28. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
[TBL] [Abstract][Full Text] [Related]
29. Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol.
Kveiborg B; Christiansen B; Major-Petersen A; Torp-Pedersen C
Am J Cardiovasc Drugs; 2006; 6(4):209-17. PubMed ID: 16913822
[TBL] [Abstract][Full Text] [Related]
30. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Torp-Pedersen C; Metra M; Charlesworth A; Spark P; Lukas MA; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Remme WJ; Scherhag A;
Heart; 2007 Aug; 93(8):968-73. PubMed ID: 17237130
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.
Albergati F; Paternó E; Venuti RP; Boeri D; Lombardo I; Semino S; Viviani GL; Adezati L
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S86-9. PubMed ID: 1378156
[TBL] [Abstract][Full Text] [Related]
32. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
33. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.
Ozbilen S; Eren MA; Turan MN; Sabuncu T
Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552
[TBL] [Abstract][Full Text] [Related]
34. Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study.
Kveiborg B; Hermann TS; Major-Pedersen A; Christiansen B; Rask-Madsen C; Raunsø J; Køber L; Torp-Pedersen C; Dominguez H
Cardiovasc Diabetol; 2010 May; 9():21. PubMed ID: 20500877
[TBL] [Abstract][Full Text] [Related]
35. β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol.
Vardeny O; Nicholas G; Andrei A; Buhr KA; Hermanson MP; Moran JJ; Detry MA; Stein JH
Am J Hypertens; 2012 Aug; 25(8):920-6. PubMed ID: 22647787
[TBL] [Abstract][Full Text] [Related]
36. Carvedilol versus Metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: rationale and design of the Carvedilol or Metoprolol Post-Revascularization Atrial Fibrillation Controlled Trial (COMPACT).
Kamei M; Morita S; Hayashi Y; Kanmura Y; Kuro M
Cardiovasc Drugs Ther; 2006 Jun; 20(3):219-27. PubMed ID: 16794788
[TBL] [Abstract][Full Text] [Related]
37. Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
Remme WJ; Torp-Pedersen C; Cleland JG; Poole-Wilson PA; Metra M; Komajda M; Swedberg K; Di Lenarda A; Spark P; Scherhag A; Moullet C; Lukas MA
J Am Coll Cardiol; 2007 Mar; 49(9):963-71. PubMed ID: 17336720
[TBL] [Abstract][Full Text] [Related]
38. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
[TBL] [Abstract][Full Text] [Related]
39. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
Torp-Pedersen C; Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lutiger B; Metra M; Remme WJ; Scherhag A; Skene A;
Am Heart J; 2005 Feb; 149(2):370-6. PubMed ID: 15846279
[TBL] [Abstract][Full Text] [Related]
40. Use of carvedilol in hypertension: an update.
Leonetti G; Egan CG
Vasc Health Risk Manag; 2012; 8():307-22. PubMed ID: 22661898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
